Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 7, 2010, Pages 1353-1358

  Castanheira, Mariana ^a   Watters, Amy A ^a   Mendes, Rodrigo E ^a   Farrell, David J ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Europe; FusA mutations; FusB; FusC; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; FUSIDIC ACID; PROTEIN FUSA; PROTEIN FUSB; PROTEIN FUSC; PROTEIN FUSD; PROTEIN FUSE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; ELONGATION FACTOR G; FUSA PROTEIN, STAPHYLOCOCCUS AUREUS; FUSB PROTEIN, STAPHYLOCOCCUS AUREUS;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BELGIUM; BROTH DILUTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; EUROPE; FRANCE; GENE MUTATION; GENE SEQUENCE; GEOGRAPHY; GERMANY; ISRAEL; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLAND; PREVALENCE; PROTEIN ANALYSIS; PULSED FIELD GEL ELECTROPHORESIS; SPAIN; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; SWEDEN; SWITZERLAND; UNITED KINGDOM; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CHEMISTRY; CLASSIFICATION; DNA FINGERPRINTING; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION; MOLECULAR GENETICS; PROCEDURES; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EUROPE; FUSIDIC ACID; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEPTIDE ELONGATION FACTOR G; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 77954186721     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq094     Document Type: Article

References (17)

1. Dobie D, Gray J. Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 2004; 89:74-7.
2. Turnidge J, Collignon P. Resistance to fusidic acid. Int J Antimicrob Agents 1999; 12 Suppl 2: S35-44.
3. Lannergard J, Norstrom T, Hughes D. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 2059-65.
4. O'Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol 2006; 59: 664-76.
5. O'Neill AJ, McLaws F, Kahlmeter G et al. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother 2007; 51: 1737-40.
6. Norstrom T, Lannergard J, Hughes D. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 4438-46.
7. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M7-A8. CLSI, Wayne, PA, USA, 2009.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
9. Castanheira M, Watters AA, Bell J et al. Fusidic acid (CEM-102) resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. from North America and Australia. Antimicrob Agents Chemother 2010; in press.
10. Mendes RE, Kiyota KA, Monteiro J et al. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007; 45: 544-7.
11. Mendes RE, Sader HS, Deshpande LM et al. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol 2010; 48: 568-74.
12. McLaws F, Chopra I, O'Neill AJ. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother 2008; 61: 1040-3.
13. Besier S, Ludwig A, Brade V et al. Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Molec Microbiol 2003; 47: 463-9.
14. Nagaev I, Bjorkman J, Andersson DI et al. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433-9.
15. Larsen AR, Skov RL, Jarlier V et al. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 2008; 61: 589-94.
16. O'Neill AJ, Larsen AR, Skov R et al. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007; 45: 1505-10.
17. Laurent F, Tristan A, Croze M et al. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France. J Antimicrob Chemother 2009; 63: 420-1.